Search

everythinglearnresearchcommunity

for

Search:↓

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Some birth control pills increase blood clot risk; use them for specific conditions only.

34% of patients on hepatitis C treatment had reversible skin issues.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

The document's conclusion cannot be provided because the document is not accessible or understandable.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

FT-Raman spectroscopy is effective for identifying drug polymorphs, ensuring quality and stability.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Copaiba resin oil shows promise for cancer therapy and is safe for topical use.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Stopping nalfurafine reversed hair loss in a hemodialysis patient.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Cepharanthine could be a strong antiviral against COVID-19.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

Some gonadal hormone drugs can block filovirus entry into cells.

Five FDA-approved drugs may help block COVID-19 virus entry.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients, but longer follow-up is needed.

A Chinese family had a child with a specific gene mutation causing vitamin D-resistant rickets, but the child improved with calcium and low-dose calcitriol.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.